Placeholder Banner

BIO Applauds Passage of Federal Approach to GMO Disclosure

July 14, 2016

Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure. 

“The Congress’ strong, bipartisan support for a national GMO labeling and disclosure solution is a win for consumers, farmers, businesses, and agricultural innovation,” said Jim Greenwood, BIO’s President and CEO.

“More than one thousand stakeholder organizations came together in support of this agreement and we commend the many leaders in the U.S. Congress for making this issue a top priority,” added Greenwood.  “We are pleased that President Obama has said he will sign this important bill.”

Discover More
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…